{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:48:56Z","timestamp":1790279336525,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Zhejiang Key Specialties of Clinical Features","award":["2024021"],"award-info":[{"award-number":["2024021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10067-026-08158-z","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:31:33Z","timestamp":1778171493000},"page":"3981-3994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global burden and inequalities of rheumatoid arthritis in adults aged 15\u201349\u00a0years from 1990 to 2021 and projections to 2050: a cross-sectional analysis from Global Burden of Disease Study 2021"],"prefix":"10.1007","volume":"45","author":[{"given":"Bo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0641-041X","authenticated-orcid":false,"given":"Haijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"10416","key":"8158_CR1","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","volume":"402","author":"A Di Matteo","year":"2023","unstructured":"Di Matteo A, Bathon JM, Emery P (2023) Rheumatoid arthritis. Lancet (London, England) 402(10416):2019\u201333","journal-title":"Lancet (London, England)"},{"issue":"10","key":"8158_CR2","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"GBD 2021 Rheumatoid Arthritis Collaborators","year":"2023","unstructured":"GBD 2021 Rheumatoid Arthritis Collaborators (2023) Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 5(10):e594\u2013e610","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"8158_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92150-1","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Gao X, Liu S, Wang Q, Wang Y, Hou S et al (2025) Global, regional, and national epidemiology of rheumatoid arthritis among people aged 20-54 years from 1990 to 2021. Sci Rep 15(1):10736","journal-title":"Sci Rep"},{"issue":"1","key":"8158_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41927-023-00365-4","volume":"7","author":"L Kirkeskov","year":"2023","unstructured":"Kirkeskov L, Bray K (2023) Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis. BMC Rheumatol 7(1):41","journal-title":"BMC Rheumatol"},{"key":"8158_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10926-024-10217-8","author":"KG Dobson","year":"2024","unstructured":"Dobson KG, Gignac MAM, Tucker L, Jetha A (2024) Double trouble! do workplace supports mitigate lost productivity for young workers with both severe rheumatic diseases and depressive symptoms? J Occup Rehabil. https:\/\/doi.org\/10.1007\/s10926-024-10217-8","journal-title":"J Occup Rehabil"},{"issue":"6","key":"8158_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325127","volume":"20","author":"J Li","year":"2025","unstructured":"Li J, Li Z, Hao C, Chen X (2025) Global burden and regional disparities of rheumatoid arthritis among the working-age population: a comprehensive analysis from 1990 to 2021 with projections to 2040. PLoS One 20(6):e0325127","journal-title":"PLoS One"},{"issue":"10","key":"8158_CR7","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae SC, Thomas R, Deane KD et al (2022) Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 18(10):591\u2013602","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"8158_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71676-6","volume":"10","author":"T Ohno","year":"2020","unstructured":"Ohno T, Aune D, Heath AK (2020) Adiposity and the risk of rheumatoid arthritis: a systematic review and meta-analysis of cohort studies. Sci Rep 10(1):16006","journal-title":"Sci Rep"},{"key":"8158_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002055","author":"G Adami","year":"2022","unstructured":"Adami G, Pontalti M, Cattani G, Rossini M, Viapiana O, Orsolini G et al (2022) Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2021-002055","journal-title":"RMD Open"},{"issue":"1","key":"8158_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40364-025-00760-8","volume":"13","author":"Y Ma","year":"2025","unstructured":"Ma Y, Chen H, Lv W, Wei S, Zou Y, Li R et al (2025) Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the Global Burden of Disease study 2021. Biomark Res 13(1):47","journal-title":"Biomark Res"},{"issue":"4","key":"8158_CR11","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.5114\/aoms\/183955","volume":"20","author":"M Zhang","year":"2024","unstructured":"Zhang M, Li M, Hu H, Li X, Tian M (2024) Global, regional, and national burdens of rheumatoid arthritis in young adults from 1990 to 2019. Arch Med Sci 20(4):1153\u20131162","journal-title":"Arch Med Sci"},{"issue":"9","key":"8158_CR12","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/rheumatology\/keae265","volume":"63","author":"R Watanabe","year":"2024","unstructured":"Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K et al (2024) Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study. Rheumatology (Oxford) 63(9):2418\u20132426","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8158_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1093\/rheumatology\/keae212","volume":"64","author":"SL Heckert","year":"2025","unstructured":"Heckert SL, Maassen JM, Nevins I, Baudoin P, Steup-Beekman GM, Huizinga TWJ et al (2025) Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies. Rheumatology (Oxford) 64(3):1052\u20131059","journal-title":"Rheumatology (Oxford)"},{"key":"8158_CR14","unstructured":"World Health Organization (2023) Rheumatoid arthritis [Internet]. World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rheumatoid-arthritis. Accessed 5 Oct\u00a02025"},{"key":"8158_CR15","unstructured":"GBD 2021 Diseases and Injuries Collaborators (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet\u00a0(London, England)\u00a0403(10440):2133\u20132161"},{"key":"8158_CR16","doi-asserted-by":"crossref","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","DOI":"10.1002\/art.27584"},{"issue":"12","key":"8158_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12(12):1495\u20139","journal-title":"Int J Surg"},{"issue":"10062","key":"8158_CR18","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M et al (2016) Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 388(10062):e19\u2013e23","journal-title":"Lancet"},{"key":"8158_CR19","unstructured":"GBD 2021 Risk Factors Collaborators (2021) Risk Factors Collaborators (2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403(10440):2162\u20132203"},{"key":"8158_CR20","unstructured":"GBD 2016 SDG Collaborators\u00a0(2017) Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet 390(10100):1423\u20131459"},{"issue":"3\u20134","key":"8158_CR21","first-page":"171","volume":"50","author":"P Das Gupta","year":"1994","unstructured":"Das Gupta P (1994) Standardization and decomposition of rates from cross-classified data. Genus 50(3\u20134):171\u201396","journal-title":"Genus"},{"key":"8158_CR22","volume-title":"World Population Prospects 2022","author":"United Nations Department of Economic, Social Affairs PD","year":"2022","unstructured":"United Nations Department of Economic, Social Affairs PD (2022) World Population Prospects 2022. United Nations, New York"},{"key":"8158_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-005383","author":"K Tang","year":"2025","unstructured":"Tang K, Zhu L, Shan S, Luo Z, Zhou J, Ying J et al (2025) Global, regional and national trends in the epidemiology of rheumatoid arthritis from 1990 to 2021: an age-period-cohort effect analysis of the Global Burden of Disease Study 2021. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2024-005383","journal-title":"RMD Open"},{"issue":"3","key":"8158_CR24","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1097\/JS9.0000000000002260","volume":"111","author":"J Li","year":"2025","unstructured":"Li J, Pandian V, Davidson PM, Song Y, Chen N, Fong DYT (2025) Burden and attributable risk factors of non-communicable diseases and subtypes in 204 countries and territories, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Int J Surg (London, England) 111(3):2385\u20132397","journal-title":"Int J Surg (London, England)"},{"key":"8158_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102193","volume":"64","author":"GBD 2019 IMID Collaborators","year":"2023","unstructured":"GBD 2019 IMID Collaborators (2023) Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the Global Burden of Disease Study 2019. EClinicalMedicine 64:102193","journal-title":"EClinicalMedicine"},{"issue":"2","key":"8158_CR26","first-page":"119","volume":"52","author":"N Carrier","year":"2025","unstructured":"Carrier N, Roux S, Masetto A, de Brum-Fernandes AJ, Liang P, Maoui M et al (2025) Changes at presentation in patients with early rheumatoid arthritis: a 24-year study of the Early Undifferentiated Polyarthritis (EUPA) Cohort. J Rheumatol 52(2):119\u2013127","journal-title":"J Rheumatol"},{"issue":"6","key":"8158_CR27","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1093\/rheumatology\/keaf045","volume":"64","author":"A Gupta","year":"2025","unstructured":"Gupta A, Anis S, de Pablo P (2025) Imaging tests as predictors of progression to rheumatoid arthritis in clinically suspect arthralgia: a systematic review and meta-analysis. Rheumatology (Oxford) 64(6):3255\u20133265","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"8158_CR28","doi-asserted-by":"publisher","DOI":"10.1289\/EHP10710","volume":"131","author":"J Zhang","year":"2023","unstructured":"Zhang J, Fang XY, Wu J, Fan YG, Leng RX, Liu B et al (2023) Association of combined exposure to ambient air pollutants, genetic risk, and incident rheumatoid arthritis: a prospective cohort study in the UK Biobank. Environ Health Perspect 131(3):37008","journal-title":"Environ Health Perspect"},{"key":"8158_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118557","volume":"302","author":"BB Feng","year":"2025","unstructured":"Feng BB, Zhang YX, Dai XY, Nie MQ, Liu YY, Ma RW et al (2025) Association of ambient air pollution with incident rheumatoid arthritis, subsequent respiratory diseases, and death: a multi-state analysis of a prospective cohort. Ecotoxicol Environ Saf 302:118557","journal-title":"Ecotoxicol Environ Saf"},{"key":"8158_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu17091557","author":"Y Dong","year":"2025","unstructured":"Dong Y, Greenwood DC, Hardie LJ, Cade JE (2025) Measures of adiposity and risk of rheumatoid arthritis in middle-aged UK women: a prospective cohort study. Nutrients. https:\/\/doi.org\/10.3390\/nu17091557","journal-title":"Nutrients"},{"issue":"2","key":"8158_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/tobaccocontrol-2021-056535","volume":"31","author":"X Dai","year":"2022","unstructured":"Dai X, Gakidou E, Lopez AD (2022) Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control 31(2):129\u2013137","journal-title":"Tob Control"},{"issue":"10431","key":"8158_CR32","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024) Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403(10431):1027\u20131050","journal-title":"Lancet"},{"issue":"1","key":"8158_CR33","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/S2665-9913(24)00221-2","volume":"7","author":"MD Russell","year":"2025","unstructured":"Russell MD, Gibson M, Zuckerman B, Kumar K, Dubey S, Adas MA et al (2025) Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study. Lancet Rheumatol 7(1):e44\u2013e54","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"8158_CR34","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/acr.25408","volume":"76","author":"L Gossec","year":"2024","unstructured":"Gossec L, Bessette L, Xavier RM, Favalli EG, \u00d6st\u00f6r A, Buch MH (2024) Barriers to, facilitators of, and interventions to support treat-to-target implementation in rheumatoid arthritis: a systematic review. Arthritis Care Res 76(12):1626\u20131636","journal-title":"Arthritis Care Res"},{"key":"8158_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002658","author":"PC Taylor","year":"2022","unstructured":"Taylor PC, Fautrel B, Piette Y, Romero-Yuste S, Broen J, Welcker M et al (2022) Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2022-002658","journal-title":"RMD Open"},{"issue":"7","key":"8158_CR36","first-page":"1516","volume":"41","author":"W Yang","year":"2023","unstructured":"Yang W, Xu Y, Lin J, Liu J, Tan Y, Chen J et al (2023) Global, regional and national burden of rheumatoid arthritis, and attributable risk factors from 1990 to 2019: update from the Global Burden of Disease 2019 study. Clin Exp Rheumatol 41(7):1516\u20131527","journal-title":"Clin Exp Rheumatol"},{"key":"8158_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.689698","volume":"8","author":"VC Rom\u00e3o","year":"2021","unstructured":"Rom\u00e3o VC, Fonseca JE (2021) Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review. Front Med 8:689698","journal-title":"Front Med"},{"issue":"1","key":"8158_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s41927-025-00501-2","volume":"9","author":"J Ainsworth","year":"2025","unstructured":"Ainsworth J, Bolic M, Ismail I, Mohammadpour Z, Wood J (2025) Sociodemographic and economic barriers to initial specialist care for patients with rheumatoid arthritis: a scoping review. BMC Rheumatol 9(1):76","journal-title":"BMC Rheumatol"},{"issue":"3","key":"8158_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/rheumatology\/kead261","volume":"63","author":"SS Zhao","year":"2024","unstructured":"Zhao SS, Rogers K, Kearsley-Fleet L, Watson K, Bosworth A, Galloway J et al (2024) Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis. Rheumatology (Oxford) 63(3):648\u2013656","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"8158_CR40","doi-asserted-by":"publisher","first-page":"e635","DOI":"10.1016\/S2665-9913(22)00136-9","volume":"4","author":"Z Paskins","year":"2022","unstructured":"Paskins Z, Farmer CE, Manning F, Andersson DA, Barlow T, Bishop FL et al (2022) Research priorities to reduce the impact of musculoskeletal disorders: a priority setting exercise with the Child Health and Nutrition Research Initiative method. Lancet Rheumatol 4(9):e635\u2013e45","journal-title":"Lancet Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08158-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08158-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08158-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:27:38Z","timestamp":1783398458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08158-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8158"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08158-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available, de-identified aggregate data from GBD 2021 and did not involve human participants directly. The Institutional Review Board of Ningbo No. 2 Hospital determined that this analysis was exempt from review and waived informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}